Theophylline (Anhydrous) (THEOPHYLLINE ANHYDROUS)
Theophylline (Anhydrous) (THEOPHYLLINE ANHYDROUS) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Theophylline (Anhydrous); Generic name: THEOPHYLLINE ANHYDROUS; Drug class: Methylxanthine [EPC].
| Brand name | Theophylline (Anhydrous) |
|---|---|
| Generic name | THEOPHYLLINE ANHYDROUS |
| Drug class | Methylxanthine [EPC] |
| Manufacturer | Westminster Pharmaceuticals, LLC |
| Used for | INDICATIONS AND USAGE Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. |
| Dosage | DOSAGE AND ADMINISTRATION Theophylline (Anhydrous) Extended-Release Tablets 400 or 600 mg can be taken once a day in the morning or evening. It is recommended that Theophylline (Anhydrous) Extended-Release Tablets be taken with meals. Patients should be advised that if they choose to take Theophylline (Anhydrous) Extended-Release Tablets with food it should be taken consistently with food and if they take it in a fasted condition it should routinely be taken fasted. It is important that the prod |
| Warnings | WARNINGS Concurrent Illness Theophylline should be used with extreme caution in patients with the following clinical conditions due to the increased risk of exacerbation of the concurrent condition: Active peptic ulcer disease Seizure disorders Cardiac arrhythmias (not including bradyarrhythmias) Conditions That Reduce Theophylline Clearance There are several readily identifiable causes of reduced theophylline clearance. If the total daily dose is not appropriately reduced in the presence of the |
| Active ingredient(s) | THEOPHYLLINE ANHYDROUS |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04f1d1da-ce61-45b3-acf4-903cc81d16da |